Industry Resources

1470 nm Diode Laser Effectiveness in Facial Fat Reduction with the Endolifting Technique: Pilot Study

1470 nm Diode Laser Effectiveness in Facial Fat Reduction with the Endolifting Technique: Pilot Study

The endolifting technique, using a 1470 nm diode laser, aims to reduce subcutaneous fat and tone the skin by stimulating collagen production. In this study, 10 patients underwent a single endolifting session on the mandibular and submental regions using a 400-micron optical fiber with 4-8 W power in continuous mode. Post-procedure, patients wore bandages for 4 days and received 4 sessions of manual lymphatic drainage weekly. After 60 days, there was a significant reduction in facial and submental fat, with improved skin tightness and reduced wrinkles. The technique proved effective and safe, with no complications observed.


LEARN MORE
Efficacy of Endolift laser for arm and under abdomen fat reduction

Efficacy of Endolift laser for arm and under abdomen fat reduction

Non invasive laser treatments for body fat contouring are growing in popularity due to fewer side effects and shorter recovery periods compared to surgical options. This study evaluated the efficacy of the Endolift laser for reducing excess fat in the arms and under abdomen in ten patients. The outcomes were assessed by two blinded dermatologists and patient satisfaction. Results showed a reduction in fat and circumference in treated areas, with high patient satisfaction and no severe adverse effects. The study concludes that the Endolift laser is an effective, safe, and cost-efficient alternative to surgical body fat contouring, requiring minimal recovery time and no general anesthesia.


LEARN MORE
Effect of the wide-spread use of endovenous laser ablation on the treatment of varicose veins in Japan: a large-scale, single institute study

Effect of the wide-spread use of endovenous laser ablation on the treatment of varicose veins in Japan: a large-scale, single institute study

This study evaluates varicose vein treatments at a Japanese hospital, comparing stripping surgery and endovenous laser ablation (EVLA) with 980 nm and 1470 nm diode lasers. From October 2013 to December 2015, 289 patients were assessed. EVLA using the 1470 nm laser showed shorter operative times (22 minutes vs. 31 minutes for the 980 nm laser) and less pain. The EVLA group had a 99.6% occlusion rate after two years. EVLA with the 1470 nm laser is recommended for saphenous vein reflux, though traditional surgery is necessary for veins >20 mm or highly tortuous veins.


LEARN MORE
Twenty Years’ Experience with Endovenous Laser Ablation forVaricose Veins: A Critical Appraisalof the Original Procedure

Twenty Years’ Experience with Endovenous Laser Ablation forVaricose Veins: A Critical Appraisalof the Original Procedure

Endovenous laser ablation (EVLA) for varicose veins is conducted in an ambulatory setting using tumescent local anesthesia (TLA). Technical advancements have reduced the need for multiple incisions, re-punctures, and minimized complications such as ecchymosis and technical failures. Using a 1470-nm diode laser with a radial fiber has enhanced patient satisfaction and lowered complication rates. The appropriate administration of TLA via infusion pump has decreased nerve injury risk, administration time, and procedural pain. High ligation and stripping are now rarely indicated. Over the past 20 years, EVLA has become an effective, cost-efficient, and safe procedure with high patient satisfaction.


LEARN MORE
Prospects of Endovenous Laser Ablation (EVLA) Standardization—Mid-Term Results of a Four-Zone Dosimetry Guiding Tool for 1940 nm Laser

Prospects of Endovenous Laser Ablation (EVLA) Standardization—Mid-Term Results of a Four-Zone Dosimetry Guiding Tool for 1940 nm Laser

This study presents mid-term results of endovenous laser ablation (EVLA) using a 1940 nm laser and radial fiber, supported by a four-zone dosimetry tool for standardization. The tool defines four anatomical zones for great saphenous veins (GSV) and two for small saphenous veins (SSV) with specific power levels. In 152 patients (185 procedures) with an 11.9-month mean follow-up, GSV occlusion rates were 98.9% at 1 month and 93.7% at 12 months. Complications were minimal, including laser-induced paraesthesia (2.2%) and endovenous heat-induced thrombosis (1.6%) at 1 month. The proposed tool standardizes EVLA dosimetry and shows promising results.


LEARN MORE